VRTX

Vertex Pharmaceuticals (VRTX)

About Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Details

Daily high
$462.00
Daily low
$454.46
Price at open
$457.78
52 Week High
$519.68
52 Week Low
$362.50
Market cap
115.6B
Dividend yield
0.00%
Volume
911,424
Avg. volume
1.4M
P/E ratio
32.10

Vertex Pharmaceuticals News

Details

Daily high
$462.00
Daily low
$454.46
Price at open
$457.78
52 Week High
$519.68
52 Week Low
$362.50
Market cap
115.6B
Dividend yield
0.00%
Volume
911,424
Avg. volume
1.4M
P/E ratio
32.10